• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Alex Azar, who was deputy secretary of HHS under former President George W. Bush, said that his experience implementing part D of Medicare, the portion of the program that pays for medicines, made him qualified to tackle the issue of drug prices. (AP Photo/Evan Vucci)
    Healthcare

    HHS nominee Alex Azar vows to tackle rising drug prices

    Kimberly Leonard -
    November 29, 2017 2:09 pm
    0
    We must shed light on the activities of the PBMs and expose them as the mobsters they are. (AP Photo/Matt Rourke, File)
    Beltway Confidential

    The Sopranos of the pharmaceutical industry

    Kevin Campbell -
    November 27, 2017 4:58 pm
    0
    While there are already some abuse-deterrent painkillers on the market, they are only brand name drugs that are more expensive than a generic. (AP Photo/Eckehard Schulz)
    Healthcare

    FDA pushes for generic painkillers intended to deter abuse

    Robert King -
    November 21, 2017 3:35 pm
    0
    People in Ohio, including some residents of Steubenville, voted against a ballot initiative that would require the state to pay no more for prescription drugs than the federal Department of Veterans Affairs does. However, the man behind the ballot, Michael Weinstein, hopes to get it on several states' ballots ahead of next year's mid-term elections. (Jmiller wiki / Wikimedia Commons)
    Beltway Confidential

    The Drug Price Relief Act, defeated soundly in Ohio last week, is coming to a state near you in 2018

    Salena Zito -
    November 15, 2017 10:45 pm
    0
    Kratom tastes like green tea when it's brewed and sometimes is taken as a pill. (AP Photo/Mary Esch, File)
    Healthcare

    Kratom, a possible heroin treatment, faces unclear fate after FDA warning

    Steven Nelson -
    November 14, 2017 7:54 pm
    0
    President Trump on Monday picked Alex Azar to lead the Department of Health and Human Services, drawing immediate scrutiny from Democrats who pointed out his tenure at the helm of drug maker Eli Lilly's U.S. division. (AP Photo/Evan Vucci)
    Healthcare

    Democrats plan to use HHS pick Alex Azar to push Trump on high drug prices

    Robert King -
    November 14, 2017 5:01 am
    0
    The Abilify MyCite drug has a digital tracking system that will tell doctors whether patients have swallowed their medication. (AP Photo/Andrew Harnik, File)
    Healthcare

    FDA approves first-of-its-kind antipsychotic that tracks whether patients are taking it

    Kimberly Leonard -
    November 14, 2017 2:04 am
    0
    Former interviews with President Trump's pick for Health and Human Services shed some light on his stances regarding pharmaceutical pricing and Obamacare.
			(AP Photo/Michel Euler)
    Healthcare

    Trump’s health secretary pick called Obamacare ‘fundamentally broken,’ faces drug pricing questions

    Kimberly Leonard -
    November 13, 2017 10:28 pm
    0
    The challenge of helping individuals with severe pain often leads physicians to overextend the dosage, or, due to fear of over-prescribing, they provide too little. (iStock Photo)
    Healthcare

    Caregivers need help navigating the opioid crisis

    Peter Rosenberger -
    November 12, 2017 5:01 am
    0
    According to the DEA official, drug manufacturers are making
    News

    Justice Department and DEA expand scheduling and charging for fentanyl-related substances

    Kelly Cohen -
    November 9, 2017 7:32 pm
    0
    1...105106107...159Page 106 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.